Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Willson
S Lawrence

Showing results (1291-1300 of 1,504) with videos related to

Pageof 151
Sort By:
Neoplasia (New York, N.Y.)|April 9, 2014
KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradationShirish Shukla, Uday Sankar Allam, Aarif Ahsan, et al.
Cancer Medicine|June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advancesAlex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
Journal of Crohn'S & Colitis|August 11, 2021
The Phenotypic Spectrum of New-onset IBD in Canadian Children of South Asian Ethnicity: A Prospective Multi-Centre Comparative StudyJ Dhaliwal, M W Carroll, J C deBruyn, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 20, 2021
UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett's Progression to Esophageal AdenocarcinomaParamita Ray, Derek J Nancarrow, Daysha Ferrer-Torres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2017
Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung CancerRobert T Dess, Yilun Sun, Martha M Matuszak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2011
Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibitionLeslie A Parsels, Yushen Qian, Daria M Tanska, et al.
Molecular Cancer Research : MCR|July 17, 2024
GRAIL1 Stabilizes Misfolded Mutant p53 through a Ubiquitin Ligase-Independent, Chaperone Regulatory FunctionParamita Ray, Sangeeta Jaiswal, Daysha Ferrer-Torres, et al.
Nature Biotechnology|September 12, 2017
Analysis of somatic microsatellite indels identifies driver events in human tumorsYosef E Maruvka, Kent W Mouw, Rosa Karlic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 27, 2017
Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationshipPeter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
JCI Insight|December 21, 2021
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypesAndrea M Pesch, Nicole H Hirsh, Anna R Michmerhuizen, et al.
Pageof 151

Showing results (1291-1300 of 1,504) with videos related to

Sort By:
Pageof 151
Neoplasia (New York, N.Y.)|April 9, 2014
KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradationShirish Shukla, Uday Sankar Allam, Aarif Ahsan, et al.
Cancer Medicine|June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advancesAlex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
Journal of Crohn'S & Colitis|August 11, 2021
The Phenotypic Spectrum of New-onset IBD in Canadian Children of South Asian Ethnicity: A Prospective Multi-Centre Comparative StudyJ Dhaliwal, M W Carroll, J C deBruyn, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 20, 2021
UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett's Progression to Esophageal AdenocarcinomaParamita Ray, Derek J Nancarrow, Daysha Ferrer-Torres, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2017
Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung CancerRobert T Dess, Yilun Sun, Martha M Matuszak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2011
Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibitionLeslie A Parsels, Yushen Qian, Daria M Tanska, et al.
Molecular Cancer Research : MCR|July 17, 2024
GRAIL1 Stabilizes Misfolded Mutant p53 through a Ubiquitin Ligase-Independent, Chaperone Regulatory FunctionParamita Ray, Sangeeta Jaiswal, Daysha Ferrer-Torres, et al.
Nature Biotechnology|September 12, 2017
Analysis of somatic microsatellite indels identifies driver events in human tumorsYosef E Maruvka, Kent W Mouw, Rosa Karlic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 27, 2017
Radiation-induced lung toxicity in non-small-cell lung cancer: Understanding the interactions of clinical factors and cytokines with the dose-toxicity relationshipPeter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
JCI Insight|December 21, 2021
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypesAndrea M Pesch, Nicole H Hirsh, Anna R Michmerhuizen, et al.
Pageof 151